{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Katie", "organization": "", "rank": 1, "lastname": "THOMAS"}], "original": "By KATIE THOMAS"}, "news_desk": "Business", "slideshow_credits": null, "abstract": "Valeant Pharmaceuticals, which is under scrutiny for its drug-pricing practices, says it is adding three new members to its board, including one from shareholder Pershing Square Capital Management; stock rises.", "multimedia": [{"type": "image", "url": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbWide.jpg", "legacy": {"wide": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/03/10/business/10valeant-web1/10valeant-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/10/business/10valeant-web1/10valeant-web1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "width": 600, "subtype": "xlarge", "height": 400}, {"type": "image", "url": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"print_headline": "Valeant Takes Step to Soothe Investors", "main": "Valeant Pharmaceuticals Adds Board Members"}, "print_page": "2", "keywords": [{"value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Pershing Square Capital Management", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Boards of Directors", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Appointments and Executive Changes", "is_major": "N", "rank": "4", "name": "subject"}], "snippet": "Valeant said it had named three new directors to its board, including an executive from a major shareholder, Pershing Square Capital Management.", "source": "The New York Times", "lead_paragraph": "Valeant said it had named three new directors to its board, including an executive from a major shareholder, Pershing Square Capital Management.", "word_count": "434", "pub_date": "2016-03-10T00:00:00Z", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/03/10/business/valeant-pharmaceuticals-adds-board-members.html", "_id": "56e0328d38f0d836dc036bd2"}